NS 004

Drug Profile

NS 004

Latest Information Update: 23 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NeuroSearch
  • Class Anti-ischaemics; Antiarrhythmics; Benzimidazoles; Chlorophenols; Muscle relaxants; Small molecules
  • Mechanism of Action Potassium channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Ischaemic heart disorders

Most Recent Events

  • 28 Mar 2000 No-Development-Reported for Ischaemic heart disorders in Denmark (Unknown route)
  • 21 Feb 1996 An animal study has been added to the pharmacodynamics section for Ischaemic Heart Disease.
  • 24 Oct 1995 Preclinical development for Ischaemic heart disorders in Denmark (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top